Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Muhammad A Saleem is active.

Publication


Featured researches published by Muhammad A Saleem.


Journal of Neuroimaging | 2018

Intra-arterial Modulation of the Trigeminal Nerve Ganglion in Patients with Refractory Trigeminal Neuralgia

Adnan I. Qureshi; Muhammad A Saleem; Vikram Jadhav; Shawn S. Wallery; Faisal Raja

Nerves and nerve ganglions are supplied by segmental arteries and the vasa nervorum, but the intra‐arterial route has not been used for diagnostic or therapeutic purposes. We present the results of intra‐arterial delivery of medication for modulating trigeminal nerve ganglion function in patients with refractory trigeminal neuralgia.


Journal of Neuroimaging | 2017

Imaging of the Vasa Nervorum Using Contrast‐Enhanced Ultrasound

Adnan I. Qureshi; Muhammad A Saleem; Asad Ahrar; Faisal Raja

We describe the use of intravenous contrast‐enhanced ultrasonography to study vasa nervorum using contrast‐enhanced ultrasound.


Journal of NeuroInterventional Surgery | 2017

Subclinical ischemic events in patients undergoing carotid artery stent placement: comparison of proximal and distal protection techniques

Emrah Aytac; Erdem Gürkaş; Çetin Kürşad Akpınar; Muhammad A Saleem; Adnan I. Qureshi

Objective To determine the relative effectiveness of proximal and distal protection in prevention of cerebral ischemic events during carotid artery stent (CAS) placement using diffusion-weighted MRI (DW-MRI). Methods We analyzed data from patients who had undergone DW-MRI before and within 24 hours of CAS for symptomatic internal carotid artery (ICA) stenosis (with last ischemic events within 3 months). The study was performed prospectively; patients were not randomized, and were treated either with a proximal balloon occlusion system (Mo.Ma; Invatec, Roncadelle, Italy) or filter-type distal protection device (Spider device; ev3, Plymouth, Minnesota, USA). Results Of the 45 patients (mean age±SD: 66.9±9.8 years; 73.3% were men) who underwent CAS, 19 had proximal protection and 26 distal protection. New ischemic lesions were detected in 26/45 patients on DW-MRI scans obtained within 24 hours after CAS. The proportion of patients with new lesions on DW-MRI at 24 hours was not different between the two groups (47.4% vs 65.4% for proximal and distal protection, respectively). The mean number of new ischemic lesions on post-CAS DW-MRI was non-significantly higher in patients who underwent CAS with distal protection (2.80±3.54 for proximal protection vs 4.96±5.11 for distal protection; p=0.12). The proportion of patients with new lesions >1 cm did not differ between the two groups (5.3% for proximal protection vs 11.5% for distal protection; p=0.62). There was no difference in the rates of ischemic stroke between patients who underwent CAS treatment using proximal and distal protection (5.3% vs 7.7%; p=1.000). Conclusions We found a relatively high rate of new ischemic lesions in patients undergoing CAS with cerebral protection. There was no difference in the proportion of patients with new lesions between patients treated using distal protection and those treated using proximal protection.


Journal of Stroke & Cerebrovascular Diseases | 2018

Vertebral Artery Occlusive Disease: Data from the Angiographically Confirmed Vertebral Artery Disease Registry

Adnan I. Qureshi; Sehar Babar; Omar Saeed; Muhammad A Saleem; Shawn S. Wallery

BACKGROUND We performed this study to identify demographic, clinical, and angiographic characteristics of adult patients with angiographically confirmed vertebral artery occlusive disease (VAOD) and associated risk factors. METHODS The demographic and clinical characteristics, and angiographic features were ascertained using predefined criteria. Controls were selected from the National Health and Nutrition Examination Surveys matched according to age, sex, and ethnicity. A stepwise logistic regression for odds ratio (OR) was performed to identify the effects of risk factors on occurrence of VAOD. RESULTS Of 56 patients with VAOD (mean age ± standard deviation [SD]; 65.4 ± 11.7years, 44.6% women), 37.5% were classified as suffering from moderate stenosis (50%-69%), 16.1% from severe stenosis (70%-99%), and 46.4% from occlusion of at least 1 vertebral artery. There was a significantly higher severity of stenosis (percentage with SD; 88.1 ± 16.5 versus 75.4 ± 20.8, P = .02) and frequency of bilateral vertebral artery disease in patients with ischemic symptoms (40.9% versus 8.8%, P = .004). In the multivariate analysis, hypertension (OR 3.0; 95% confidence interval [CI], 1.4-6.5), diabetes mellitus (OR 2.5; 95% CI, 1.4-4.6), coronary artery disease (OR 3.2; 95% CI, 1.7-6.0), and active cigarette smoking (OR 3.1; 95% CI, 1.5-6.3) were significantly associated with vertebral artery disease. CONCLUSIONS Severity of stenosis and bilateral involvement were associated with symptomatic VAOD. Hypertension, diabetes mellitus, coronary artery disease, and active cigarette smoking were associated with occurrence of VAOD.


Headache | 2018

Migraine and Non-Migraine Headaches Following Diagnostic Catheter-Based Cerebral Angiography

Adnan I. Qureshi; Nishath Naseem; Muhammad A Saleem; Anvita Potluri; Faisal M. Raja; Shawn S. Wallery

No reliable estimates of headaches following catheter‐based cerebral angiography are available. We performed an observational cohort study to ascertain the frequency and type of headaches following catheter‐based cerebral angiography.


Journal of Neuroimaging | 2017

Postprocedure Subarachnoid Hemorrhage after Endovascular Treatment for Acute Ischemic Stroke

Adnan I. Qureshi; Muhammad A Saleem; Emrah Aytac

The rate of occurrence and associated outcomes of subarachnoid hemorrhage (SAH) in acute ischemic stroke patients following endovascular treatment is not well studied.


Stroke | 2018

Abstract TP195: Frequency of and Factors Associated With “Stroke on Wheels” in United States: An Analysis of National Emergency Department Sample 2013-2014

Muhammad A Saleem; Nishath Naseem; Adnan I. Qureshi


JVIN | 2018

Effectiveness of topical lidocaine-prilocaine cream for pain control during femoral artery catheterization in adult patients: A prospective study

Adnan Qureshi; Muhammad A Saleem; Nishath Naseem; Emrah Aytac; Çetin Kürşad Akpınar; Shawn S. Wallery


Stroke | 2017

Abstract WP67: Ultra-early Institution of Statin Treatment is Associated With Improved Outcomes Among Acute Ischemic Stroke Patients Receiving Thrombolytic Treatment

Adnan I. Qureshi; Muhammad A Saleem


Stroke | 2017

Abstract WP319: Prevalence and Trends of Insomnia Among Stroke Survivors in United States: National Health and Nutrition Examination Surveys 2005 to 2015

Adnan I. Qureshi; Sher Afgan; Muhammad A Saleem

Collaboration


Dive into the Muhammad A Saleem's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Muhammad Shah Miran

Texas Tech University Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Faisal Raja

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar

Ahmed Malik

University of Minnesota

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ihtesham A. Qureshi

Texas Tech University Health Sciences Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge